Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Aurinia Pharm Ord (NASDAQ: AUPH)

$6.97 USD -$0.12 (-1.69%)
Last Price $6.97
Net Change $-0.12 (-1.69%)
Bid $6.91
Ask Price $7.06
Open Price $7.11
Previous Close Price $7.09
High Price $7.12
Low Price $6.88
Number of Trades 6,157
Volume 1,959,906
Fifty Two Week High $10.54 (2017-03-13)
Fifty Two Week Low $1.74 (2016-08-15)
Average Daily Volume 6,827,813
Share Outstanding 83,270 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $23.19
Recent Earnings $
Annual EPS $-0.75
Last Quarter EPS $
Market Capitalization $0.58B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 83,270
Inst. Shareholder % 44.21%
Annual Net Income $-0.07B
TTM Net Profit Margin $-47313.33
1-Year Return 185.89%
3-Year Return 93.66%
5-Year Return 245.85%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 23.190001%
Dividends per Share $
Stock Split Ratio 1-50
Beta 2.65
Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

AUPH News & Stock Updates